Cargando…

Toll-Like Receptor-Based Strategies for Cancer Immunotherapy

Toll-like receptors (TLRs) are expressed and play multiple functional roles in a variety of immune cell types involved in tumor immunity. There are plenty of data on the pharmacological targeting of TLR signaling using agonist molecules that boost the antitumor immune response. A recent body of rese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pahlavanneshan, Saghar, Sayadmanesh, Ali, Ebrahimiyan, Hamidreza, Basiri, Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166496/ https://www.ncbi.nlm.nih.gov/pubmed/34124272 http://dx.doi.org/10.1155/2021/9912188

Ejemplares similares

Generation and Functional Characterization of PLAP CAR-T Cells against Cervical Cancer Cells
por: Yekehfallah, Vahid, et al.
Publicado: (2022)

Evaluation of Placental Alkaline Phosphatase Expression as A Potential Target of Solid Tumors Immunotherapy by Using Gene and Protein Expression Repositories
por: Basiri, Mohsen, et al.
Publicado: (2021)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Induction of ß Cell Replication by Small Molecule-Mediated Menin Inhibition and Combined PKC Activation and TGF-ß Inhibition as Revealed by A Refined Primary Culture Screening
por: Pahlavanneshan, Saghar, et al.
Publicado: (2021)

Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands
por: Rostamizadeh, Leila, et al.
Publicado: (2022)

Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists
por: Jeong, Sehwan, et al.
Publicado: (2021)

Enhanced characterization of beta cell mass in a Tg(Pdx1-GFP) mouse model
por: Karami, Fatemeh, et al.
Publicado: (2022)

Toll-Like Receptor-4 Modulation for Cancer Immunotherapy
por: Awasthi, Shanjana
Publicado: (2014)

Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
por: Muccioli, Maria, et al.
Publicado: (2014)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
por: Huang, Lingling, et al.
Publicado: (2022)

Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2020)

T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells
por: Nouri, Yasmin, et al.
Publicado: (2021)

Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy
por: Hoden, Bettina, et al.
Publicado: (2023)

Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
por: Andón, Fernando Torres, et al.
Publicado: (2022)

Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
por: Sun, Hao, et al.
Publicado: (2022)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Application potential of toll-like receptors in cancer immunotherapy: Systematic review
por: Shi, Ming, et al.
Publicado: (2016)

Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy
por: Hoden, Bettina, et al.
Publicado: (2022)

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
por: Chakraborty, Samik, et al.
Publicado: (2023)

Toll-like receptor-associated keratitis and strategies for its management
por: Kaur, Amandeep, et al.
Publicado: (2015)

Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
por: Deng, Shuanglin, et al.
Publicado: (2014)

Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
por: Farooq, Mariya, et al.
Publicado: (2021)

Systemic cancer immunotherapy with Toll-like receptor 7 agonists: Timing is everything
por: Hotz, Christian, et al.
Publicado: (2012)

Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy
por: Matsumoto, Misako, et al.
Publicado: (2017)

The application of Toll like receptors for cancer therapy
por: So, Eui Young, et al.
Publicado: (2010)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

Toll-Like Receptors in Atherosclerosis
por: Falck-Hansen, Mika, et al.
Publicado: (2013)

Toll-like Receptors and Thrombopoiesis
por: Tang, Xiaoqin, et al.
Publicado: (2023)

Toll-like Receptor 4 Modulation as a Strategy to Treat Sepsis
por: Wittebole, X., et al.
Publicado: (2010)

Characterization of CAR T Cells Manufactured Using Genetically Engineered Artificial Antigen Presenting Cells
por: Sayadmanesh, Ali, et al.
Publicado: (2023)

Toll-Like Receptors in Angiogenesis
por: Grote, Karsten, et al.
Publicado: (2011)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Toll-like Receptors from the Perspective of Cancer Treatment
por: Javaid, Nasir, et al.
Publicado: (2020)

Toll-like receptors and NOD-like receptors in rheumatic diseases
por: McCormack, William J, et al.
Publicado: (2009)

Toll-like Receptors in Viral Encephalitis
por: Gern, Olivia Luise, et al.
Publicado: (2021)

Toll-like receptor downstream signaling
por: Kawai, Taro, et al.
Publicado: (2005)

Toll-like receptor 4 in atherosclerosis
por: Li, Hongli, et al.
Publicado: (2007)

Toll-like receptors in lupus nephritis
por: Devarapu, Satish Kumar, et al.
Publicado: (2018)

The Role of Toll-Like Receptors in Oncotherapy
por: Liu, Caiqi, et al.
Publicado: (2019)

Toll-like Receptors and Celiac Disease
por: Talipova, Diana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p3u7to3a2ps8v6pspvep8na089